Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
Clinical trial NCT04526730 · COMPLETED
Trial details
- NCT number
- NCT04526730
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2024-03-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.